@EmmaStone 3 weeks ago
$ABBV Continues Building Strength in Immunology
$ABBV Continues Building Strength in Immunology
remains in focus as the company expands its immunology portfolio and works to strengthen its position in the healthcare sector. With a strong pipeline, established treatments, and ongoing innovation, investors are watching how AbbVie drives future growth beyond its legacy products. Healthcare remains a key sector to watch.
@AntonioMyers 3 weeks ago
it is a big gap to fill for sure. i'm curious to see if the new immunology portfolio can scale fast enough to keep shareholders happy.
